Biomarkers for exposure to sand flies bites as tools to aid control of leishmaniasis

Frontiers in Immunology

Volumn 3, Issue MAY, 2012, Pages

  Andrade, Bruno Bezerril ^a   Teixeira, Clarissa R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Biomarkers; Leishmaniasis; Salivary proteins; Sand fly; Vectors

Indexed keywords

EID: 84874064729     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00121     Document Type: Review

References (49)

1. Andrade, B. B., Rocha, B. C., Reis-Filho, A., Camargo, L. M., Tadei, W. P., Moreira, L. A., Barral,A., and Barral-Netto, M. (2009). Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. Malar. J. 8, 121.
2. Andrade, B. B., Teixeira, C. R., Barral, A., and Barral-Netto, M. (2005). Haematophagous arthropod saliva and host defense system: a tale of tear and blood. An. Acad. Bras. Cienc. 77, 665-693.
3. Aquino, D. M., Caldas, A. J., Miranda, J. C., Silva, A. A., Barral-Netto, M., and Barral, A. (2010). Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen. Am. J. Trop. Med. Hyg. 83, 825-827.
4. Bahia, D., Gontijo, N. F., Leon, I. R., Perales, J., Pereira, M. H., Oliveira, G., Correa-Oliveira, R., and Reis, A. B. (2007). Antibodies from dogs with canine visceral leishmaniasis recognise two proteins from the saliva of Lutzomyia longipalpis. Parasitol. Res. 100, 449-454.
5. Barral, A., Honda, E., Caldas, A., Costa, J., Vinhas, V., Rowton, E. D., Valenzuela, J. G., Charlab, R., Barral-Netto, M., and Ribeiro, J. M. (2000). Human immune response to sand fly salivary gland antigens: a useful epidemiological marker? Am. J. Trop. Med. Hyg. 62, 740-745.
6. Belkaid, Y., Kamhawi, S., Modi, G., Valenzuela, J., Noben-Trauth, N., Rowton, E., Ribeiro, J., and Sacks, D. L. (1998). Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J. Exp. Med. 188, 1941-1953.
7. Brummer-Korvenkontio, H., Lappalainen, P., Reunala, T., and Palosuo, T. (1994). Detection of mosquito saliva-specific IgE and IgG4 antibodies by immunoblotting. J. Allergy Clin. Immunol. 93, 551-555.
8. Clements, M. F., Gidwani, K., Kumar, R., Hostomska, J., Dinesh, D. S., Kumar, V., Das, P., Muller, I., Hamilton, G., Volfova, V., Boelaert, M., Das, M., Rijal, S., Picado, A., Volf, P., Sundar, S., Davies, C. R., and Rogers, M. E. (2010). Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral leishmaniasis, by using human antibody responses to sand fly saliva. Am. J. Trop. Med. Hyg. 82, 801-807.
9. Collin, N., Gomes, R., Teixeira, C., Cheng, L., Laughinghouse, A., Ward, J. M., Elnaiem, D. E., Fischer, L., Valenzuela, J. G., and Kamhawi, S. (2009). Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania. PLoS Pathog. 5, e1000441. doi:10.1371/journal.ppat.1000441
10. de Moura, T. R., Oliveira, F., Novais, F. O., Miranda, J. C., Clarencio, J., Follador, I., Carvalho, E. M., Valenzuela, J. G., Barral-Netto, M., Barral, A., Brodskyn, C., and De Oliveira, C. I. (2007). Enhanced Leishmania braziliensis infection following preexposure to sandfly saliva. PLoS Negl. Trop. Dis. 1, e84. doi:10.1371/journal.pntd.0000084
11. Doucoure, S., Mouchet, F., Cornelie, S., Dehecq, J. S., Rutee, A. H., Roca, Y., Walter, A., Herve, J. P., Misse, D., Favier, F., Gasque, P., and Remoue, F. (2012). Evaluation of the human IgG antibody response to Aedes albopictus saliva as a new specific biomarker of exposure to vector bites. PLoS Negl. Trop. Dis. 6, e1487. doi:10.1371/journal.pntd.0001487
12. Fontaine, A., Pascual, A., Orlandi-Pradines, E., Diouf, I., Remoue, F., Pages, F., Fusai, T., Rogier, C., and Almeras, L. (2011). Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts. PLoS ONE 6, e29107. doi:10.1371/journal.pone.0029107
13. Gidwani, K., Picado, A., Rijal, S., Singh, S. P., Roy, L., Volfova, V., Andersen, E. W., Uranw, S., Ostyn, B., Sudarshan, M., Chakravarty, J., Volf, P., Sundar, S., Boelaert, M., and Rogers, M. E. (2011). Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial. PLoS Negl. Trop. Dis. 5,e1296. doi:10.1371/journal.pntd.0001296
14. Gomes, R., Teixeira, C., Teixeira, M. J., Oliveira, F., Menezes, M. J., Silva, C., De Oliveira, C. I., Miranda, J. C., Elnaiem, D. E., Kamhawi, S., Valenzuela, J. G., and Brodskyn, C. I. (2008). Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc. Natl. Acad. Sci. U.S.A. 105, 7845-7850.
15. Gomes, R. B., Brodskyn, C., De Oliveira, C. I., Costa, J., Miranda, J. C., Caldas, A., Valenzuela, J. G., Barral-Netto, M., and Barral, A. (2002). Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity. J. Infect. Dis. 186, 1530-1534.
16. Gomes, R. B., Mendonca, I. L., Silva, V. C., Ruas, J., Silva, M. B., Cruz, M. S., Barral, A., and Costa, C. H. (2007). Antibodies against Lutzomyia longipalpis saliva in the fox Cerdocyon thous and the sylvatic cycle of Leishmania chagasi. Trans. R. Soc. Trop. Med. Hyg. 101, 127-133.
17. Hostomska, J., Rohousova, I., Volfova, V., Stanneck, D., Mencke, N., and Volf, P. (2008). Kinetics of canine antibody response to saliva of the sand fly Lutzomyia longipalpis.Vector Borne Zoonotic Dis. 8, 443-450.
18. Kamhawi, S. (2000). The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections. Microbes Infect. 2, 1765-1773.
19. Lane, R. S., Moss, R. B., Hsu, Y. P., Wei, T., Mesirow, M. L., and Kuo, M. M. (1999). Anti-arthropod saliva antibodies among residents of a community at high risk for Lyme disease in California. Am. J. Trop. Med. Hyg. 61, 850-859.
20. Lanzaro, G. C., Lopes, A. H., Ribeiro, J. M., Shoemaker, C. B., Warburg, A., Soares, M., and Titus, R. G. (1999). Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex. Insect Mol. Biol. 8, 267-275.
21. Marzouki, S., Ben Ahmed, M., Boussoffara, T., Abdeladhim, M., Ben Aleya-Bouafif, N., Namane, A., Hamida, N. B., Ben Salah, A., and Louzir, H. (2011). Characterization of the antibody response to the saliva of Phlebotomus papatasi in people living in endemic areas of cutaneous leishmaniasis. Am. J. Trop. Med. Hyg. 84, 653-661.
22. Morris, R. V., Shoemaker, C. B., David, J. R., Lanzaro, G. C., and Titus, R. G. (2001). Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J. Immunol. 167, 5226-5230.
23. Murray, H. W., Berman, J. D., Davies, C. R., and Saravia, N. G. (2005). Advances in leishmaniasis. Lancet 366, 1561-1577.
24. Nascimento, R. J., Santana, J. M., Lozzi, S. P.,Araujo,C. N.,and Teixeira,A. R. (2001). Human IgG1 and IgG4: the main antibodies against Triatoma infestans (Hemiptera: Reduviidae) salivary gland proteins. Am. J. Trop. Med. Hyg. 65, 219-226.
25. Oliveira, F., Lawyer, P. G., Kamhawi, S., and Valenzuela, J. G. (2008). Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease. PLoS Negl. Trop. Dis. 2, e226. doi:10.1371/journal.pntd.0000226
26. Orlandi-Pradines, E., Almeras, L., Denis De Senneville, L., Barbe, S., Remoue, F., Villard, C., Cornelie, S., Penhoat, K., Pascual, A., Bourgouin, C., Fontenille, D., Bonnet, J., CorreCatelin, N., Reiter, P., Pages, F., Laffite, D., Boulanger, D., Simondon, F., Pradines, B., Fusai, T., and Rogier, C. (2007). Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa. Microbes Infect. 9, 1454-1462.
27. Palosuo, K., Brummer-Korvenkontio, H., Mikkola, J., Sahi, T., and Reunala, T. (1997). Seasonal increase in human IgE and IgG4 antisaliva antibodies to Aedes mosquito bites. Int. Arch. Allergy Immunol. 114, 367-372.
28. Remoue, F., Cisse, B., Ba, F., Sokhna, C., Herve, J. P., Boulanger, D., and Simondon, F. (2006). Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria. Trans. R. Soc. Trop. Med. Hyg. 100, 363-370.
29. Rohousova, I., Hostomska, J., Vlkova, M., Kobets, T., Lipoldova, M., and Volf, P. (2011). The protective effect against Leishmania infection conferred by sand fly bites is limited to short-term exposure. Int. J. Parasitol. 41, 481-485.
30. Rohousova, I., Ozensoy, S., Ozbel, Y., and Volf, P. (2005). Detection of species-specific antibody response of humans and mice bitten by sand flies. Parasitology 130, 493-499.
31. Sanders, M. L., Jaworski, D. C., Sanchez, J. L., Defraites, R. F., Glass, G. E., Scott, A. L., Raha, S., Ritchie, B. C., Needham, G. R., and Schwartz, B. S. (1998). Antibody to a cDNAderived calreticulin protein from Amblyomma americanum as a biomarker of tick exposure in humans. Am. J. Trop. Med. Hyg. 59, 279-285.
32. Schwartz, B. S., Ford, D. P., Childs, J. E., Rothman, N., and Thomas, R. J. (1991). Anti-tick saliva antibody: a biologic marker of tick exposure that is a risk factor for Lyme disease seropositivity. Am. J. Epidemiol. 134, 86-95.
33. Schwartz, B. S., Ribeiro, J. M., and Goldstein, M. D. (1990). Anti-tick antibodies: an epidemiologic tool in Lyme disease research. Am.J.Epidemiol. 132, 58-66.
34. Schwarz, A., Helling, S., Collin, N., Teixeira, C. R., Medrano-Mercado, N., Hume, J. C., Assumpcao, T. C., Marcus, K., Stephan, C., Meyer, H. E., Ribeiro, J. M., Billingsley, P. F.,Valenzuela, J. G., Sternberg, J. M., and Schaub, G. A. (2009). Immunogenic salivary proteins of Triatoma infestans: development of a recombinant antigen for the detection of low-level infestation of triatomines. PLoS Negl. Trop. Dis. 3, e532. doi:10.1371/journal.pntd.0000532
35. Schwarz, A., Juarez, J. A., Richards, J., Rath, B., Machaca, V. Q., Castro, Y. E., Malaga, E. S., Levy, K., Gilman, R. H., Bern, C., Verastegui, M., and Levy, M. Z. (2011). Anti-triatomine saliva immunoassays for the evaluation of impregnated netting trials against Chagas disease transmission. Int. J. Parasitol. 41, 591-594.
36. Schwarz, A., Medrano-Mercado, N., Billingsley, P. F., Schaub, G. A., and Sternberg, J. M. (2010). IgMantibody responses of chickens to salivary antigens of Triatoma infestans as early biomarkers for lowlevel infestation of triatomines. Int. J. Parasitol. 40, 1295-1302.
37. Silva, F., Gomes, R., Prates, D., Miranda, J. C., Andrade, B., Barral-Netto, M., and Barral, A. (2005). Inflammatory cell infiltration and high antibody production in BALB/c mice caused by natural exposure to Lutzomyia longipalpis bites. Am. J. Trop. Med. Hyg. 72, 94-98.
38. Souza, A. P., Andrade, B. B., Aquino, D., Entringer, P., Miranda, J. C., Alcantara, R., Ruiz, D., Soto, M., Teixeira, C. R., Valenzuela, J. G., De Oliveira, C. I., Brodskyn, C. I., Barral-Netto, M., and Barral, A. (2010). Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral leishmaniasis endemic areas. PLoS Negl. Trop. Dis. 4, e649. doi:10.1371/journal.pntd.0000649
39. Tavares, N. M., Silva, R. A., Costa, D. J., Pitombo, M. A., Fukutani, K. F., Miranda, J. C., Valenzuela, J. G., Barral, A., De Oliveira, C. I., Barral-Netto, M., and Brodskyn, C. (2011). Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia. PLoS Negl. Trop. Dis. 5, e1169. doi:10.1371/journal.pntd.0001169
40. Teixeira, C., Gomes, R., Collin, N., Reynoso, D., Jochim, R., Oliveira, F., Seitz, A., Elnaiem, D. E., Caldas, A., De Souza, A. P., Brodskyn, C. I., De Oliveira, C. I., Mendonca, I., Costa, C. H., Volf, P., Barral, A., Kamhawi, S., and Valenzuela, J. G. (2010). Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America. PLoS Negl. Trop. Dis. 4, e638. doi:10.1371/journal.pntd.0000638
41. Thiakaki, M., Rohousova, I., Volfova, V., Volf, P., Chang, K. P., and Soteriadou, K. (2005). Sand fly specificity of saliva-mediated protective immunity in Leishmania amazonensis-BALB/c mouse model. Microbes Infect. 7, 760-766.
42. Titus, R. G., and Ribeiro, J. M. (1988). Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 239, 1306-1308.
43. Valenzuela, J. G., Belkaid, Y., Rowton, E., and Ribeiro, J. M. (2001). The salivary apyrase of the bloodsucking sand fly Phlebotomus papatasi belongs to the novel Cimex family of apyrases. J. Exp. Biol. 204, 229-237.
44. Vinhas, V., Andrade, B. B., Paes, F., Bomura, A., Clarencio, J., Miranda, J. C., Bafica, A., Barral, A., and Barral-Netto, M. (2007). Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis. Eur. J. Immunol. 37, 3111-3121.
45. Vlkova, M., Rohousova, I., Drahota, J., Stanneck, D., Kruedewagen, E. M., Mencke, N., Otranto, D., and Volf, P. (2011). Canine antibody response to Phlebotomus perniciosus bites negatively correlates with the risk of Leishmania infantum transmission. PLoS Negl. Trop. Dis. 5, e1344. doi:10.1371/journal.pntd.0001344
46. Volf, P. (1991). Polyplax spinulosa infestation and antibody response in various strains of laboratory rats. Folia Parasitol. 38, 355-362.
47. Volf, P., Grubhoffer, L., and Hosek, P. (1993). Characterisation of salivary gland antigens of Triatoma infestans and antigen-specific serum antibody response in mice exposed to bites of T. infestans. Vet. Parasitol. 47, 327-337.
48. Volf, P., and Rohousova, I. (2001). Species-specific antigens in salivary glands of phlebotomine sandflies. Parasitology 122(Pt 1), 37-41.
49. Structure and function of a yellow protein from saliva of the sand fly Lutzomyia longipalpis that confers protective immunity against Leishmania major infection